Skip to main content
SpringerLink
Log in

Butyrylcholinesterase and γ-Glutamyltransferase Activities and Oxidative Stress Markers Are Altered in Metabolic Syndrome, But Are Not Affected by Body Mass Index

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Metabolic syndrome (MetS) leads to changes in enzymatic activities, oxidative and inflammatory parameters. Adenosine deaminase (ADA), dipeptidyl peptidase IV (DPP-IV), butyrylcholinesterase (BuChE) and γ-glutamyltransferase (γ-GT) activities, C-reactive protein (hsCRP) and nitric oxide levels (NOx), as well as oxidative stress markers were analyzed in 39 subjects with MetS and 48 controls. Also, the influence of body mass index (BMI) and anthropometric measurements were evaluated. Disturbances in antioxidant defenses and higher γ-GT and BuChE activities, NOx and hsCRP levels were observed in subjects with MetS. These findings remained associated with MetS after adjustment for BMI, except for hsCRP. ADA was correlated with age, insulin levels and HOMA-IR index in MetS. DPP-IV and total cholesterol (TC), BuChE activity and TC, and VIT C and hsCRP levels also were correlated. The analyzed parameters may reflect the inflammatory state of the MetS, and could contribute to prevention and control of various aspects of this syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

REFERENCES

  1. Grundy, S.M., J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Jr Smith, J.A. Spertus, and F. Costa. 2005. American Heart Association; National Heart, Lung, and Blood Institute, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752.

    Article  PubMed  Google Scholar 

  2. Phillips, C., J. Lopez-Miranda, F. Perez-Jimenez, R. McManus, and H.M. Roche. 2006. Genetic and nutrient determinants of the metabolic syndrome. Current Opinion in Cardiology 21: 185–193.

    Article  PubMed  Google Scholar 

  3. Batsis, J.A., R.E. Nieto-Martinez, and F. Lopez-Jimenez. 2007. Metabolic syndrome: from global epidemiology to individualized medicine. Clinical Pharmacology and Therapeutics 82: 509–524.

    Article  PubMed  CAS  Google Scholar 

  4. Marquezine, G.F., C.M. Oliveira, A.C. Pereira, J.E. Krieger, and J.G. Mill. 2008. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction. International Journal of Cardiology 129: 259–265.

    Article  PubMed  Google Scholar 

  5. Kuno, M., N. Seki, S. Tsujimoto, I. Nakanishi, T. Kinoshita, K. Nakamura, T. Terasaka, N. Nishio, A. Sato, and T. Fujii. 2006. Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. European Journal of Pharmacology 534: 241–249.

    Article  PubMed  CAS  Google Scholar 

  6. Conlon, B.A., and W.R. Law. 2004. Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses. Clinical and Experimental Immunology 138: 14–20.

    Article  PubMed  CAS  Google Scholar 

  7. Prakash, M.S., S. Chennaiah, Y.S.R. Murthy, E. Anjaiah, S. Ananda Rao, and C. Suresh. 2006. Altered adenosine deaminase activity in type 2 diabetes mellitus. Journal Indian Academy of Clinical Medicine 7: 114–117.

    Google Scholar 

  8. Bopp, A., K.S. De Bona, L.P. Bellé, R.N. Moresco, and M.B. Moretto. 2009. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients. Fundamental and Clinical Pharmacology 23: 501–507.

    Article  PubMed  CAS  Google Scholar 

  9. Kurtul, N., S. Pence, E. Akarsu, H. Kocoglu, Y. Aksoy, and H. Aksoy. 2004. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Médica 47: 33–35.

    PubMed  CAS  Google Scholar 

  10. Dong, R.P., J. Kameoka, M. Hegen, T. Tanaka, Y. Xu, S.F. Schlossman, and C. Morimoto. 1996. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. The Journal of Immunology 156: 1349–1355.

    PubMed  CAS  Google Scholar 

  11. Stancíková, M., Z. Lojda, J. Lukác, and M. Ruzicková. 1992. Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Clinical and Experimental Rheumatology 10: 381–385.

    PubMed  Google Scholar 

  12. Lugari, R., A. Dei Cas, D. Ugolotti, A.L. Barilli, C. Camellini, G.C. Ganzerla, A. Luciani, B. Salerni, F. Mittenperger, S. Nodari, A. Gnudi, and R. Zandomeneghi. 2004. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Hormone and Metabolism Research 36: 111–115.

    Article  CAS  Google Scholar 

  13. Ryskjaer, J., C.F. Deacon, R.D. Carr, T. Krarup, S. Madsbad, J. Holst, and T. Vilsbøll. 2006. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. European Journal of Endocrinology 155: 485–493.

    Article  PubMed  CAS  Google Scholar 

  14. De Bona, K.S., G. Bonfanti, L.O. Cargnelutti, P.E. Bitencourt, P.S. da Silva, R. Ceolin, V.C. Pimentel, and M.B. Moretto. 2012. Lymphocytic enzymes and lipid peroxidation in patients with metabolic syndrome. Clinical Biochemistry 45: 1081–1085.

    Article  PubMed  Google Scholar 

  15. Randell, E.W., M.S. Mathews, H. Zhang, J.S. Seraj, and G. Sun. 2005. Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clinical Biochemistry 38: 799–805.

    Article  PubMed  CAS  Google Scholar 

  16. Abbott, C.A., M.I. Mackness, S. Kumar, A.O. Olukoga, C. Gordon, S. Arrol, D. Bhatnagar, A.J. Boulton, and P.N. Durrington. 1993. Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clinical Science 85: 77–81.

    PubMed  CAS  Google Scholar 

  17. Alcantara, V.M., E.A. Chautard-Freire-Maia, M. Scartezini, M.S. Cerci, K. Braun-Prado, and G. Picheth. 2002. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation 62: 399–404.

    Article  PubMed  CAS  Google Scholar 

  18. Vaidya, D., M. Szklo, M. Cushman, P. Holvoet, J. Polak, H. Bahrami, N.S. Jenny, and P. Ouyang. 2011. Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multi-ethnic study of atherosclerosis. European Journal of Clinical Nutrition 65: 818–825.

    Article  PubMed  CAS  Google Scholar 

  19. Sun, Y.X., S.J. Hu, X.H. Zhang, J. Sun, C.H. Zhu, and Z.J. Zhang. 2006. Plasma levels of vWF and NO in patients with metabolic syndrome and their relationship with metabolic disorders. Zhejiang Da Xue Xue Bao. Yi Xue Ban 35: 315–318.

    PubMed  CAS  Google Scholar 

  20. Zahedi Asl, S., A. Ghasemi, and F. Azizi. 2008. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clinical Biochemistry 41: 1342–1347.

    Article  PubMed  CAS  Google Scholar 

  21. Koh, K.K., M.J. Quon, S.H. Han, W.J. Chung, J.A. Kim, and E.K. Shin. 2006. Vascular and metabolic effects of candesartan: insights from therapeutic interventions. Journal of Hypertension. Supplement 24: 31–38.

    Article  Google Scholar 

  22. Assumpção, C.R., T.M.C. Brunini, C. Matsuura, A.C. Resende, and A.C. Mendes- Ribeiro. 2008. Impact of the l-arginine-nitric oxide pathway and oxidative stress on the pathogenesis of the metabolic syndrome. Open Biochemistry Journal 2: 108–115.

    Article  Google Scholar 

  23. Friedewald, W.T., R.I. Levy, and D.S. Fredrickson. 1972. Estimation of concentration of low-density lipoprotein in plasma, without use of preparative ultracentrifuge. Clinical Chemistry 18: 499–502.

    PubMed  CAS  Google Scholar 

  24. Matthews, D.R., J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.

    Article  PubMed  CAS  Google Scholar 

  25. Giusti, G., and C. Gakis. 1971. Temperature conversion factors, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissues. Enzyme 12: 417–425.

    PubMed  CAS  Google Scholar 

  26. Jarmołowska, B., K. Bielikowicz, M. Iwan, K. Sidor, E. Kostyra, and M. Kaczmarski. 2007. Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy. Peptides 28: 678–682.

    Article  PubMed  Google Scholar 

  27. Ellman, G.C., K.D. Courtney, V. Andres, and R.M. Feather- Stone. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7: 88–95.

    Article  PubMed  CAS  Google Scholar 

  28. Tatsch, E., G.V. Bochi, S. Pereira Rda, H. Kober, V.A. Agertt, M.M. de Campos, P. Gomes, M.M. Duarte, and R.N. Moresco. 2011. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clinical Biochemistry 44: 348–350.

    Article  PubMed  CAS  Google Scholar 

  29. Boyne, A.F., and G.L. Ellman. 1972. A methodology for analysis of tissue sulfhydryl components. Analytical Biochemistry 46: 639–653.

    Article  PubMed  CAS  Google Scholar 

  30. Jacqes-Silva, M.C., C.W. Nogueira, L.C. Broch, E.M. Flores, and J.B. Rocha. 2001. Diphenyl diselenide and ascorbic acid changes deposition of selenium and brain of mice. Phamacology and Toxicology 88: 119–125.

    Article  Google Scholar 

  31. Galley, H., M.J. Davies, and N.R. Webster. 1996. Ascorbil radical formation in patients with sepsis: effects of ascorbate loading. Free Radical Biology and Medicine 20: 139–143.

    Article  PubMed  CAS  Google Scholar 

  32. Lapenna, D., G. Ciofani, S.D. Pierdomenico, M.A. Giamberardino, and F. Cuccurullo. 2001. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radical Biology and Medicine 31: 331–335.

    Article  PubMed  CAS  Google Scholar 

  33. Festa, A., R. D'Agostino Jr., G. Howard, L. Mykkänen, R.P. Tracy, and S.M. Haffner. 2000. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42–47.

    Article  PubMed  CAS  Google Scholar 

  34. Ridker, P.M., J.E. Buring, N.R. Cook, and N. Rifai. 2003. C-Reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107: 391–397.

    Article  PubMed  Google Scholar 

  35. Haas, M.J., and A.D. Mooradian. 2011. Inflammation, high-density lipoprotein and cardiovascular dysfunction. Current Opinion in Infectious Diseases 24: 265–272.

    Article  PubMed  CAS  Google Scholar 

  36. Elks, C.M., and J. Francis. 2010. Central adiposity, systemic inflammation, and the metabolic syndrome. Current Hypertension Reports 12: 99–104.

    Article  PubMed  CAS  Google Scholar 

  37. Magarian, E.O., and A.J. Dietz. 1987. Correlation of cholinesterase with serum lipids and lipoproteins. The Journal of Clinical Pharmacology 27: 819–820.

    Article  CAS  Google Scholar 

  38. Sridhar, G.R., G. Nirmala, A. Apparao, A.S. Madhavi, S. Sreelatha, J.S. Rani, and P. Vijayalakshmi. 2005. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipids in Health and Disease 8: 4–18.

    Google Scholar 

  39. Kalman, J., A. Juhasz, Z. Rakonczay, G. Abrahám, M. Zana, K. Boda, T. Farkas, B. Penke, and Z. Janka. 2004. Increase serum butyrylcholinesterase activity in type IIb hyperlipidemic patients. Life Science 75: 1195–1204.

    Article  CAS  Google Scholar 

  40. Meghji, P. 1991. Adenosine production and metabolism. In Adenosine in the nervous system, ed. T. Stone, 25–42. London: Academic.

    Chapter  Google Scholar 

  41. Rosenstock, J., M.A. Baron, S. Dejager, D. Mills, and A. Schweizer. 2007. Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial. Diabetes Care 30: 217–223.

    Article  PubMed  CAS  Google Scholar 

  42. Bozbaş, H., A. Yıldırır, E. Karaçağlar, O. Demir, T. Ulus, S. Eroğlu, A. Aydınalp, B. Ozin, and H. Müderrisoğlu. 2011. Increased serum gamma glutamyltransferase activity in patients with metabolic syndrome. Türk Kardiyoloji Derneği Arşivi 39: 122–128.

    Article  PubMed  Google Scholar 

  43. Giral, P., N. Jacob, C. Dourmap, B. Hansel, A. Carrié, E. Bruckert, X. Girerd, and M.J. Chapman. 2008. Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 587–593.

    Article  PubMed  CAS  Google Scholar 

  44. Vincent, H.K., and A.G. Taylor. 2006. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. International Journal of Obesity (Lond) 30: 400–418.

    Article  CAS  Google Scholar 

  45. Doi, Y., Y. Kiyohara, M. Kubo, T. Ninomiya, Y. Wakugawa, K. Yonemoto, M. Iwase, and M. Iida. 2005. Elevated C-reactive protein is a predictor of diabetes in a general Japanese population: the Hisayama study. Diabetes Care 28: 2497–2500.

    Article  PubMed  CAS  Google Scholar 

  46. Ford, E.S. 2003. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168: 351–358.

    Article  PubMed  CAS  Google Scholar 

  47. Amiri, F. 2009. Metabolic syndrome, insulin resistance and oxidative stress: adding insights to improve cardiovascular prevention. Journal of Hypertension 27: 1352–1354.

    Article  PubMed  CAS  Google Scholar 

  48. Pischon, T., F.B. Hu, K.M. Rexrode, J.C. Girman, A.E. Manson, and E.B. Rimm. 2008. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 197: 392–399.

    Article  PubMed  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

The authors wish to thank the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Federal University of Santa Maria (UFSM), RS, Brazil, for support in this study. Also, we thank all the volunteers who participated in this study.

Conflict of Interest

No competing financial interests exist.

Author information

Authors and Affiliations

  1. Postgraduate Program in Pharmacology, Department of Clinical and Toxicology Analysis, Center of Healthy Sciences, Federal University of Santa Maria (UFSM), 97105-900, Santa Maria, RS, Brazil

    Karine S. De Bona, Gabriela Bonfanti, Melissa Premaor, Rafael N. Moresco & Maria Beatriz Moretto

  2. Postgraduate Program in Pharmaceutical Sciences, UFSM, Santa Maria, Brazil

    Paula E. R. Bitencourt, Lariane O. Cargnelutti, Priscila S. da Silva, Leidiane De Lucca, Etiane Tatsch, Thissiane L. Gonçalves, Rafael N. Moresco & Maria Beatriz Moretto

  3. Department of Chemistry, UFSM, Santa Maria, Brazil

    Victor C. Pimentel

Authors
  1. Karine S. De Bona
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriela Bonfanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paula E. R. Bitencourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lariane O. Cargnelutti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Priscila S. da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leidiane De Lucca
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Victor C. Pimentel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Etiane Tatsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Thissiane L. Gonçalves
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Melissa Premaor
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Rafael N. Moresco
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Maria Beatriz Moretto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Beatriz Moretto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Bona, K.S., Bonfanti, G., Bitencourt, P.E.R. et al. Butyrylcholinesterase and γ-Glutamyltransferase Activities and Oxidative Stress Markers Are Altered in Metabolic Syndrome, But Are Not Affected by Body Mass Index. Inflammation 36, 1539–1547 (2013). https://doi.org/10.1007/s10753-013-9697-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-013-9697-9

KEY WORDS

Search

Navigation